TrialBMC ophthalmology2014

Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial.

Harvey B DuBiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.